Biopharmaceutical Products
The manufacturing process of biosimilars is a complex endeavor, accompanied by several challenges. We will discuss some of the biggest hurdles in this article, along with solutions to overcome them.
Brian Moloney
May 14, 2024
Biopharmaceutical Products
The development process of biosimilars slightly differs from the one of their reference biologics. In this article, we will discuss each phase in detail.
Michael Eder
May 13, 2024
Biopharmaceutical Products
As biologics have become a central pillar in today’s healthcare sector, their manufacturing process increasingly draws attention. In this article, we will discuss the process step by step, including challenges and possible ways to overcome them.
Michael Eder
May 13, 2024
Biopharmaceutical Products
Establishing both efficient and safe manufacturing processes for biosimilars requires planning, expertise, and state-of-the-art equipment. In this article, we will shed light on different steps in the manufacturing process and discuss ways to improve them.
Michael Eder
May 8, 2024
Biopharmaceutical Products
Freezing and thawing are essential steps in the cold chain management of biosimilars. With several methods eligible, we have chosen some prominent ones, explaining their advantages, limitations, and our preferred choices.
Alexander Fuchs
May 8, 2024
Biopharmaceutical Products
Over the years, several biosimilars have been approved as alternatives for often more costly biologics. We have listed them, along with the product they refer to.
Michael Mühlegger
May 8, 2024
Biopharmaceutical Products
Biosimilars are a popular alternative to reference biologics they resemble. But what has led to this popularity, and what’s to know about their manufacturing? Find out in this article!
Michael Eder
May 8, 2024
Biopharmaceutical Products
In the past few decades, biologics have become an integral pillar in healthcare worldwide. Deriving from living organisms, they hold huge therapeutic potential, with many possible applications still undiscovered. In this article, we will give you an overview of this exciting class of pharmaceuticals.
Michael Eder
May 8, 2024
Biopharmaceutical Products
Once biologics are produced, they need to be stored for shorter or longer periods of time, with dedicated storage requirements to be met. Here, we will uncover these requirements, along with solutions to fulfill them.
Alexander Fuchs
May 8, 2024
Biopharmaceutical Products
ADCs offer new, highly promising approaches in the therapy of various cancer types, and the number of approved ADCs is continuously growing. In this article, we will have a look at ADCs currently approved.
Michael Mühlegger
May 7, 2024
Biopharmaceutical Products
Biologics and biosimilars are both innovative and frequently used therapeutics, but where do they differ? They will be uncovered in this article.
Michael Eder
May 6, 2024
Biopharmaceutical Products
There is more than one way to prepare biologics for long-term storage under temperature-controlled conditions – in this article, we will explore some of the main freezing methods.
Alexander Fuchs
May 6, 2024
Articles by Biopharmaceutical Products:
Articles by Manufacturing Processes:
E-Book
In this publication we show that the initial price can be deceiving and there are significant additional costs during ongoing usage in the long term. Plate freezers ensure a complete, consistent, and fast freezing (and thawing) to ensure the quality of your high-valued drug substance is maintained, and through simple lifecycle analysis they outpace conventional options regarding total costs.
E-Book
Homogeneity of pharmaceuticals plays a major role in fluid management. Liquid drugs have different viscosities, degrees of sedimentation, and other varying properties, making it difficult to standardize the aliquotation of liquids. RoSS.PADL is a homogenizing solution with kneading and cooling functions for standardizing the mixing of biopharmaceuticals precedenting the dispensation into single-use bioprocess containers. This fully automated and hence standardized process ensures homogeneous distribution of the liquids in single-use bio process containers.
E-Book
This guide for bioconjugate manufacturing with regards to fluid and cold chain management addresses challenges such as: protection against ADC toxicity, accuracy in fluid management, maintaining ADC stability after freeze-thaw cycles, transition from lab to commercialization, and cost considerations of equipment.
